Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

Posted on August 19, 2024 by Vaseline

Akari Therapeutics Reports Second Quarter 2024 Financial Results and Recent Highlights

Samir R. Patel, MD Named Interim CEO; Interim CEO Employment Agreement Reflects Agreement with Shareholders

Prioritization Plan for Peak Bio’s ADC Cancer Therapeutics Platform Technology and Akari’s PAS Nomacopan for Geographic Atrophy